KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
The brochure outlines the key issues facing by the company in the listing process and how KPMG can help both in the pre & post IPO.
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Initial Public Offerings - Recently published Initial Public Offerings publications.